Why Tilray Stock Rallied After its Q3 Results

Here’s why Tilray (TSX:TLRY) stock jumped sharply after announcing its Q3 results.

| More on:

What happened?

The shares of Tilray (TSX:TLRY)(NASDAQ:TLRY) rose sharply on Wednesday after the company announced the results for Q3 of its fiscal year 2022. During the intraday trading, the TSX-listed TLRY stock jumped by about 16% yesterday before paring some of the gains in the latter half of the session, as the broader market selloff intensified.

So what?

In the third quarter ended in February 2022, Tilray registered 23% YoY (year-over-year) positive growth in its total revenue to around US$151.9 million. However, its latest quarterly revenue figure missed analysts’ estimate of US$156.8 million by a narrow margin.  While its cannabis segment revenue jumped by 32% YoY, the company registered solid 64% growth in its beverage alcohol revenue. In addition, Tilray’s international market cannabis revenue saw a massive increase.

Despite its lower-than-expected revenue, the cannabis giant pleasantly surprised investors by reporting a second consecutive profitable quarter. Tilray’s Q3 adjusted earnings stood at around US$0.09 per share against Street’s expectation of US$0.08-per-share loss. The company cited a reduction in its “assessment of the contingent consideration owed on the SweetWater transaction” as one of the factors that impacted its profits in the February quarter. These factors seemingly helped the company regain investors’ confidence, triggering a rally in TLRY stock price.

Now what?

Currency headwinds stole about US$7 million from Tilray’s distribution segment revenue in the last quarter as the euro continues to weaken against the U.S. dollar. Apart from this temporary negative factor, Tilray’s latest quarterly financial results largely reflected strong positive growth.

After the completion of the Aphria-Tilray merger in May 2021, Tilray has achieved nearly US$76 million in cost synergies. By the end of May 2022, the company expects to reach its goal of achieving US$80 million Synergy — way ahead of schedule. Also, a massive recent rise in its international market revenue reflects optimism for Tilray’s long-term business growth.

Given these positive developments, long-term investors may consider buying TLRY stock right now. Despite yesterday’s sharp rally, Tilray stock continues to underperform the main Canadian market gauge, as it’s trading with only 2% year-to-date gains.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool has no position in any of the stocks mentioned. Fool contributor Jitendra Parashar has no position in any of the stocks mentioned.

More on Cannabis Stocks

Stethoscope with dollar shaped cord
Cannabis Stocks

Best Stock to Buy Right Now: Bausch Health vs Canopy Growth?

While both stocks are risky, Bausch Health is seeing operational momentum, while Canopy Growth is still struggling with losses.

Read more »

Worker checks cannabis flower in lab farm greenhouse
Cannabis Stocks

Down an Incredible 99% From All-Time Highs, Is Canopy Growth Stock Worth Buying Now?

Canopy Growth stock remains a high-risk investment in 2025 due to its weak balance sheet and volatile profit margins.

Read more »

money goes up and down in balance
Dividend Stocks

2 Incredibly Cheap Growth Stocks to Buy Now

These two growth stocks are both unbelievably cheap and have significant long-term potential, making them some of the best to…

Read more »

A cannabis plant grows.
Stocks for Beginners

1 Canadian Cannabis Stock Down 57% to Buy Now for Future Growth

Cannabis stocks might seem so 2018, but this one could eventually make a major comeback.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »